USPTO serial 79379230
NOVACUTAN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 29, 2025
- Examiner
- PAPALE, LISA ANNE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NOVACUTAN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Amanda M. Prose
Amanda M. Prose WESTMAN, CHAMPLIN & KOEHLER, P.A.121 South Eighth Street, Suite 1100Minneapolis, MN 55402United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | cosmetic products, namely beauty creams, gels, lotions, and masks, cosmetic powders, body emulsions, beauty serums, shampoos, hair conditioners, bath foams, and body sprays; cosmetic products based on hyaluronic acid, namely beauty creams, gels, lotions, and masks, cosmetic powders, body emulsions, beauty serums, shampoos, hair conditioners, bath foams, and body sprays; cosmetic products based on hyaluronic acid for hypodermic injections | ACTIVE | — |
| 005 | pharmaceutical preparations based on Botulinum toxin type A-hemagglutinin complex for treatment of blepharospasm and chronic migraine and for use in cosmetic medicine; pharmaceutical preparations based on hyaluronic acid, namely for hypodermic injections, for treatment of arthrosis and for use in ophtalmic surgery; biological preparations for medical use for the treatment of blepharospasm and chronic migraine and for use in cosmetic medicine; biological preparations for medical use for the treatment of arthrosis and for use in ophtalmic surgery; vitamin preparations; mineral supplements; albuminous multivitamin preparations for medical use | ACTIVE | — |
| 010 | medical products, including based on hyaluronic acid, namely dermal fillers, gel filler; implants, including surgical and medical implants, including those made from materials that are artificial, intradermal, intradermal based on hyaluronic acid or hyaluronic-acid-based materials, namely implants comprising natural, non-living materials; cannulae; surgical and medical apparatus and instruments, namely injection needles with round end points with lateral eyes; implantable devices, namely implantable drug delivery ports for the subcutaneous release of medicated substances; syringes for medical use; syringes for injections; hypodermic syringes | ACTIVE | — |
| 042 | Research and development of new products, for others; biological research; scientific research services in the field of cosmetology | ACTIVE | — |
| 044 | Medical services; cosmetology services, including beautician services and artist make-up services; hygienic care services for individuals; hairdressing services; manicure services; massage; advisory services in the field of cosmetic body and beauty care; advisory services concerning medical services; consultation with respect to pharmacy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Laboratoires Fijie
- Other trademarks owned by Laboratoires Fijie
- Other trademarks owned by Laboratoires Fijie
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named NOVACUTAN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 5, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 14, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 14, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 29, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 29, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 29, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 11, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 11, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 8, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 5, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 20, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 20, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 12, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 7, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 2, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 2, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 2, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 30, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 5, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 5, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 19, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 18, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 24, 2023 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 26, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 22, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 21, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |